Macular Oedema following CRVO before Intravitreal Ozurdex Implant (OCT)
Macular Oedema following CRVO before Intravitreal Ozurdex Implant (OCT)
Patient: 59 year old lady.
Ocular Medical History: CRVO at OS in August 2012. Later on she had developed cystoid macular oedema (CMO) which was non resolving (Figure 1). We have decided to give her an intravitreal injection of Ozurdex (Dexamethasone Intravitreal Implant, 0.7mg). She had the injection in 16/04/2013.
Methods: SD-OCT, Follow-up 6 weeks.
Findings:
OCT: 04/2013: Macular edema, Vision logmar 0.7, Figure 1.
OCT: 06/2013: Mainly complete resolution of the CMO. Vision has improved from 0.7 LogMar to 0.4 LogMar, Figure 2.
Al-Aqaba, Mouhamed Ali Abdul Kareem, Ph.D., Rotherham Hospital NHS Foundation Trust, Rotherham, United Kingdom; Thakur, Shakti, M.D., Rotherham Hospital NHS Foundation Trust, Rotherham, United Kingdom
